Source link : https://newshealth.biz/health-news/osimertinibs-benefits-in-nsclc-can-extend-beyond-first-line/
Patients with EGFR-mutated NSCLC who progress on first-line osimertinib live longer without disease worsening when the drug is maintained alongside chemotherapy second line. Medscape Medical News Source link : https://www.medscape.com/viewarticle/osimertinibs-benefits-nsclc-can-extend-beyond-first-line-2025a1000nlc?src=rss Author : Publish date : 2025-09-07 19:20:00 Copyright for syndicated content belongs to the linked Source.
The post Osimertinib’s Benefits in NSCLC Can Extend Beyond First Line first appeared on News Health.
—-
Author : News Health
Publish date : 2025-09-07 19:20:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8